Smita S. Chandran

2.8k total citations
19 papers, 1.0k citations indexed

About

Smita S. Chandran is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Smita S. Chandran has authored 19 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Immunology, 14 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Smita S. Chandran's work include CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (13 papers) and Immune Cell Function and Interaction (8 papers). Smita S. Chandran is often cited by papers focused on CAR-T cell therapy research (13 papers), Immunotherapy and Immune Responses (13 papers) and Immune Cell Function and Interaction (8 papers). Smita S. Chandran collaborates with scholars based in United States, France and Germany. Smita S. Chandran's co-authors include Christopher A. Klebanoff, Biman C. Paria, Udai S. Kammula, Donna L. Färber, John R. Teijaro, Abhishek K. Srivastava, Steven G. Nadler, Robert Somerville, John R. Wunderlich and Steven A. Rosenberg and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Smita S. Chandran

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Smita S. Chandran United States 13 682 670 261 149 131 19 1.0k
Kalijn F. Bol Netherlands 21 1.3k 1.9× 1.1k 1.6× 523 2.0× 99 0.7× 79 0.6× 42 1.7k
Eckhart Kaempgen Germany 13 591 0.9× 578 0.9× 471 1.8× 116 0.8× 42 0.3× 21 1.0k
Samuel Alsén Sweden 9 513 0.8× 277 0.4× 191 0.7× 159 1.1× 56 0.4× 15 737
Yutaka Kawakami Japan 17 672 1.0× 452 0.7× 331 1.3× 69 0.5× 106 0.8× 31 1.2k
Dirk M. van der Steen Netherlands 14 432 0.6× 440 0.7× 283 1.1× 46 0.3× 145 1.1× 28 747
Marten Visser Netherlands 10 867 1.3× 869 1.3× 303 1.2× 18 0.1× 60 0.5× 15 1.1k
Takashi Inozume Japan 16 593 0.9× 669 1.0× 259 1.0× 14 0.1× 70 0.5× 52 995
Pranay D. Khare United States 10 197 0.3× 408 0.6× 193 0.7× 23 0.2× 188 1.4× 17 701
Junna Oba Japan 12 189 0.3× 227 0.3× 278 1.1× 233 1.6× 18 0.1× 24 640
Suzanne Salvi Switzerland 15 375 0.5× 220 0.3× 410 1.6× 89 0.6× 40 0.3× 30 770

Countries citing papers authored by Smita S. Chandran

Since Specialization
Citations

This map shows the geographic impact of Smita S. Chandran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Smita S. Chandran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Smita S. Chandran more than expected).

Fields of papers citing papers by Smita S. Chandran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Smita S. Chandran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Smita S. Chandran. The network helps show where Smita S. Chandran may publish in the future.

Co-authorship network of co-authors of Smita S. Chandran

This figure shows the co-authorship network connecting the top 25 collaborators of Smita S. Chandran. A scholar is included among the top collaborators of Smita S. Chandran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Smita S. Chandran. Smita S. Chandran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ma, Jiaqi, Cory M. Ayres, Smita S. Chandran, et al.. (2025). Dynamic allostery in the peptide/MHC complex enables TCR neoantigen selectivity. Nature Communications. 16(1). 849–849. 4 indexed citations
2.
Cohen, Tal, Paul Zumbo, Michael V. Gormally, et al.. (2025). Enhancing the Persistence and Anti-Tumor Efficacy of CAR-T and CAR-NK Cells through Genetic Disruption of Death Receptors. Transplantation and Cellular Therapy. 31(2). S1–S1. 1 indexed citations
3.
Ayres, Cory M., et al.. (2025). HLA micropolymorphisms confine neoantigen conformational adaptability and guide T cell receptor selectivity. bioRxiv (Cold Spring Harbor Laboratory).
4.
Cohen, Tal, Paul Zumbo, Michael V. Gormally, et al.. (2024). Abstract 40: Persistence but not antitumor efficacy of CAR-engineered lymphocytes is governed by a FAS/FAS ligand auto-regulatory circuit. Cancer Research. 84(6_Supplement). 40–40. 1 indexed citations
5.
Klebanoff, Christopher A., Smita S. Chandran, Brian M. Baker, Sergio A. Quezada, & Antoni Ribas. (2023). T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome. Nature Reviews Drug Discovery. 22(12). 996–1017. 67 indexed citations
6.
Banks, Lauren B., Smita S. Chandran, Emily K. Slotkin, et al.. (2023). 343 Defining and therapeutically targeting a fusion-derived public neoantigen in desmoplastic small round cell tumor using T-cell receptor gene therapy. SHILAP Revista de lepidopterología. A392–A392. 1 indexed citations
7.
Drakes, Dylan J., Sarwish Rafiq, Terence J. Purdon, et al.. (2020). Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy. Cancer Immunology Research. 8(6). 743–755. 24 indexed citations
8.
Gejman, Ron S., Martin G. Klatt, Aaron Y. Chang, et al.. (2020). Identification of the Targets of T-cell Receptor Therapeutic Agents and Cells by Use of a High-Throughput Genetic Platform. Cancer Immunology Research. 8(5). 672–684. 26 indexed citations
9.
Chandran, Smita S., Jiaqi Ma, Martin G. Klatt, et al.. (2019). Abstract CN01-03: T cell receptor gene therapy for a public neoantigen derived from mutated PIK3CA, a dominant driver oncogene in breast and endometrial cancers. Molecular Cancer Therapeutics. 18(12_Supplement). CN01–3. 4 indexed citations
10.
Chandran, Smita S. & Christopher A. Klebanoff. (2019). T cell receptor‐based cancer immunotherapy: Emerging efficacy and pathways of resistance. Immunological Reviews. 290(1). 127–147. 215 indexed citations
11.
Chandran, Smita S., Robert Somerville, James C. Yang, et al.. (2017). Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study. The Lancet Oncology. 18(6). 792–802. 202 indexed citations
12.
Klebanoff, Christopher A., Joseph G. Crompton, Anthony Leonardi, et al.. (2017). Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy. JCI Insight. 2(23). 160 indexed citations
13.
Rothermel, Luke D., Arvind Sabesan, Daniel J. Stephens, et al.. (2015). Identification of an Immunogenic Subset of Metastatic Uveal Melanoma. Clinical Cancer Research. 22(9). 2237–2249. 64 indexed citations
14.
Chandran, Smita S., Biman C. Paria, Abhishek K. Srivastava, et al.. (2015). Tumor-Specific Effector CD8+ T Cells That Can Establish Immunological Memory in Humans after Adoptive Transfer Are Marked by Expression of IL7 Receptor and c-myc. Cancer Research. 75(16). 3216–3226. 23 indexed citations
15.
Chandran, Smita S., Biman C. Paria, Abhishek K. Srivastava, et al.. (2014). Persistence of CTL Clones Targeting Melanocyte Differentiation Antigens Was Insufficient to Mediate Significant Melanoma Regression in Humans. Clinical Cancer Research. 21(3). 534–543. 39 indexed citations
16.
Wang, Anran, Smita S. Chandran, Biman C. Paria, et al.. (2012). The Stoichiometric Production of IL-2 and IFN-γ mRNA Defines Memory T Cells That Can Self-Renew After Adoptive Transfer in Humans. Science Translational Medicine. 4(149). 149ra120–149ra120. 45 indexed citations
17.
Chandran, Smita S., David Verhoeven, John R. Teijaro, Matthew J. Fenton, & Donna L. Färber. (2009). TLR2 Engagement on Dendritic Cells Promotes High Frequency Effector and Memory CD4 T Cell Responses. The Journal of Immunology. 183(12). 7832–7841. 32 indexed citations
18.
Teijaro, John R., David Verhoeven, Smita S. Chandran, et al.. (2009). Costimulation Modulation Uncouples Protection from Immunopathology in Memory T Cell Responses to Influenza Virus. The Journal of Immunology. 182(11). 6834–6843. 44 indexed citations
19.
Teijaro, John R., Smita S. Chandran, Agnes M. Azimzadeh, et al.. (2008). CTLA4 Expression Is an Indicator and Regulator of Steady-State CD4+FoxP3+ T Cell Homeostasis. The Journal of Immunology. 181(3). 1806–1813. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026